Elevance Health (ELV) Share-based Compensation (2010 - 2026)

Elevance Health (ELV) has 17 years of Share-based Compensation data on file, last reported at $55.0 million in Q1 2026.

• Share-based Compensation for Q1 2026 came in at $55.0 million, down 32.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $250.0 million (up 19.05% YoY), and the FY2025 annual result was $276.0 million, up 44.5% from the prior year.
• Share-based Compensation advanced to $55.0 million in Q1 2026 per ELV's latest filing, from $30.0 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $92.0 million in Q2 2024 and troughed at -$29.0 million in Q4 2024.
• A 5-year average of $63.2 million and a median of $72.0 million in 2022 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2024 and 2025: Share-based Compensation slumped 140.28% in 2024, then jumped 203.45% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $73.0 million in 2022, then fell by 1.37% to $72.0 million in 2023, then tumbled by 140.28% to -$29.0 million in 2024, then jumped by 203.45% to $30.0 million in 2025, then jumped by 83.33% to $55.0 million in 2026.
• Business Quant data shows ELV's Share-based Compensation at $55.0 million in Q1 2026, $30.0 million in Q4 2025, and $84.0 million in Q3 2025.